Primary Record
Ivosidenib
- In stock
- 3,915 g
- Purity
- 98.9 %
- CAS
- 1448347-49-6
Compound Identifiers & Properties
- CAS
- 1448347-49-6
- PubChem CID
- 71657455
- SMILES
- C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N
- Canonical SMILES
- N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1
Names & Synonyms
- Ivosidenib
- Tibsovo
- AG-120
- ivosidenibum
- 1448347-49-6
- Ivosidenib [INN]
- Ivosidenib [USAN]
- Ivosidenib [WHO-DD]
- Q2PCN8MAM6
- Tibsovo (TN)
- AG120
- UNII-Q2PCN8MAM6
- IVOSIDENIB [MI]
- RefChem:57058
- RG120
- MFCD29036964
- C28H22ClF3N6O3
- Ivosidenib (JAN/USAN/INN)
- CHEBI:145430
- Ivosidenib [USAN:INN:WHO-DD]
- DTXSID801027928
- GTPL9217
- orb1303993
- CHEMBL3989958
- IVOSIDENIB [ORANGE BOOK]
- SCHEMBL15122512
- SCHEMBL29598134
- SCHEMBL29599627
- EX-A992
- L01XX62
- WIJZXSAJMHAVGX-DHLKQENFSA-N
- BDBM363689
- DTXCID801513494
- HMS6019J07
- AMY38924
- US9850277, Compound 176
- AG 120
- EBC-17159
- NSC789102
- s8206
- 1448347-49-6 (Ivosidenib)
- AKOS028113340
- ZINC205136523
- CCG-270141
- CS-5122
- DB14568
- NSC-789102
- NCGC00476170-04
- NCGC00476170-06
- AC-32624
- AS-35058
- BP-43660
- FA145491
- HY-18767
- SY260961
- NS00133776
- J3.535.050K
- A14386
- D11090
- A857879
- A900315
- EN300-21623926
- F978977
- (S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
- 1448346-63-1
- BRD-K93073858-001-01-1
- Q27895417
- (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
- Glycinamide, 1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)-
- B0084-474585
- (2S)-2-(2-CHLOROPHENYL)-2-{1-[(2S)-1-(4-CYANOPYRIDIN-2-YL)-5-OXOPYRROLIDIN-2-YL]-N-(5-FLUOROPYRIDIN-3-YL)FORMAMIDO}-N-(3,3-DIFLUOROCYCLOBUTYL)ACETAMIDE
- (2S)-N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
- (S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-
- (S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
- (2S)-1-(4-Cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chloroPh)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-glycinamide
- (2S)-2-(2-chlorophenyl)-2-(1-((2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl)-N-(5-fluoropyridin-3-yl)formamido)-N-(3,3-difluorocyclobutyl)acetamide
- (2S)-N-((1S)-1-(2-CHLOROPHENYL)-2-((3,3-DIFLUOROCYCLOBUTYL)AMINO)-2-OXOETHYL)-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE
- (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxo-ethyl]-1-(4-cyano-2-pyridyl)-N-(5-fluoro-3-pyridyl)-5-oxo-pyrrolidine-2-carboxamide
- (2S)-N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
- (2S)-N-{(1S)-1-(2-Chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; AG 120
- (S)-N-[(S)-1-(2-Chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyano-2-pyridyl)-N-(5-fluoro-3-pyridyl)-5-oxopyrrolidine-2-carboxamide
- 2-(2-CHLOROPHENYL)-2-{1-[(2S)-1-(4-CYANOPYRIDIN-2-YL)-5-OXOPYRROLIDIN-2-YL]-N-(5-FLUOROPYRIDIN-3-YL)FORMAMIDO}-N-(3,3-DIFLUOROCYCLOBUTYL)ACETAMIDE
- Glycinamide, N2-[1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl]-2-(2-chlorophenyl)-N1-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)-;
- IV3
- N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide
- N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxo-L-prolinamide